Peter J. Facchini - Oct 13, 2021 Form 4 Insider Report for Enveric Biosciences, Inc. (ENVB)

Signature
/s/ Peter J. Facchini
Stock symbol
ENVB
Transactions as of
Oct 13, 2021
Transactions value $
$0
Form type
4
Date filed
1/25/2023, 03:30 PM
Previous filing
Oct 15, 2021
Next filing
Jan 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENVB Common Stock Award $0 +1.02K +8.28% $0.00 13.4K Oct 13, 2021 Direct F1, F2
transaction ENVB Common Stock Award $0 +10.5K +78.62% $0.00 23.9K Oct 13, 2021 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person received the restricted stock units (RSUs) as a one-time signing bonus upon the commencement of the reporting person's employment with the Company. 50% of the RSUs shall vest over 2 years in equal annual installments, with the first tranche to vest on September 16, 2022. 50% of the RSUs shall vest over 2 years in equal annual installments, if the Company's average VWAP exceeds 110% and 120% of $158.925, respectively.
F2 Includes 10,633 shares previously held through the Facchini 2020 Family Trust, which were distributed to the reporting person and are now owned directly.
F3 50% of the RSUs shall vest over 4 years in equal annual installments, with the first tranche to vest on September 16, 2022. 50% of the RSUs shall vest in 3 approximately equal tranches on each of December 31, 2022, 2023 and 2024, if the Company's average VWAP (calculated as the average over the fourth calendar quarter of each of 2022, 2023 and 2024, as applicable, of the daily volume weighted average price of a share of common stock), exceeds $119.00, $130.50 and $143.50, respectively.